Business Segments Mayinglong Pharmaceutical Group Co., LTD.
Stocks
600993
CNE000001HN2
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 22.52 CNY | +1.40% |
|
+1.67% | -19.57% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceutical Industry Division | 1.86B | 2.08B | 1.84B | 2.17B | 2.4B | |||||
Total Assets | 3.89B | 4.69B | 4.61B | 4.95B | 5.34B | |||||
Interest Expense | -5.61M | -6.44M | -2.62M | -9.35M | -2.71M | |||||
CAPEX | -38.44M | -6.37M | -22.41M | - | - | |||||
EBT | 554M | 602M | 548M | 666M | 758M | |||||
D&A | 41.79M | 43.39M | 50.23M | 53.38M | 58.8M | |||||
| - | - | - | - | 67.27M | ||||||
Pharmaceutical Product Distribution | ||||||||||
Pharmaceutical Business Segment | 1.49B | 1.38B | 1.12B | 1.29B | 1.17B | |||||
Total Assets | 470M | 619M | 573M | 558M | 559M | |||||
Interest Expense | -1.9M | -2.37M | -1.03M | -1.92M | -1.95M | |||||
CAPEX | 8.53M | 3.67M | 5.5M | - | - | |||||
EBT | 5.22M | 6.76M | -4.45M | 10.02M | 4.68M | |||||
D&A | 10.25M | 12.35M | 11.76M | 10.31M | 6.9M | |||||
| - | - | - | - | 37.11M | ||||||
Medical Services Division | 189M | 263M | 352M | 455M | 422M | |||||
Total Assets | 247M | 288M | 286M | 266M | 278M | |||||
Interest Expense | -3.67M | -4.18M | -4.07M | -3.27M | -2.7M | |||||
CAPEX | -18.49M | -36.65M | 42.74M | - | - | |||||
EBT | -20.23M | -21.31M | -9.8M | -8.02M | -15.94M | |||||
D&A | 25.19M | 18M | 23.59M | 18.8M | 15.97M | |||||
| - | - | - | - | 4.47M | ||||||
Undistributed Amount | 843K | 2.6M | 5.75M | 4.42M | 22.48M | |||||
Total Assets | 456M | 911M | 968M | 1.1B | 1.06B | |||||
Interest Expense | -188K | 572K | -9.56M | -385K | -2.83M | |||||
CAPEX | -25.33M | -50.83M | -225M | - | - | |||||
EBT | 23.38M | -27.73M | -4.51M | 388K | 3.47M | |||||
D&A | 555K | 2.83M | 3.18M | 4.15M | 15.95M | |||||
Offsets between Segments | -151M | -194M | -182M | -197M | -146M | |||||
Total Assets | -939M | -1.45B | -1.61B | -1.69B | -1.8B | |||||
Interest Expense | 1.16M | 724K | 431K | 7.55M | 2.8M | |||||
CAPEX | - | - | 4.55M | - | - | |||||
EBT | -14.32M | -532K | -4.52M | -11.16M | -40.87M | |||||
D&A | - | 1.94M | 1.33M | - | 796K | |||||
| - | - | - | - | 37.52M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Mainland China | 3.38B | 3.53B | 3.13B | 3.72B | 3.86B | |||||
| - | - | - | - | 4.04M | ||||||
outside Mainland China | 598K | 2.39M | 4.18M | 4.55M | 4.04M | |||||
Total Assets | 725M | 832M | 1.06B | 1.21B | 1.63B | |||||
| - | - | - | - | 3.86B |
Select your edition
All financial news and data tailored to specific country editions
